Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

GnRH analogue-cytotoxic molecule conjugate and preparation method and application thereof

A compound and small molecule technology, applied in the fields of chemistry and medicine, can solve problems such as toxic side effects and low stability

Inactive Publication Date: 2015-12-30
INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the research on this type of compounds has made great progress, and individual compounds have entered the clinical research stage, but there are still disadvantages of low stability, and it is easy to release cytotoxic molecules prematurely, resulting in toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • GnRH analogue-cytotoxic molecule conjugate and preparation method and application thereof
  • GnRH analogue-cytotoxic molecule conjugate and preparation method and application thereof
  • GnRH analogue-cytotoxic molecule conjugate and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0156] Example 1: Synthesis of Peptide Sequences

[0157] Using 0.5g MBHA resin (0.54mmol) as a solid phase carrier, DIC / HOBt as a condensing agent, according to the amino acid sequence of the compound, all amino acids and modification units are connected sequentially according to the Boc and Fmoc cross-protection strategies, and the above peptide resin is put into HF cutting Add 1.0mL of anisole and 0.5mL of ethanedithiol to the reactor of the instrument. After installation, the system of the HF cutting instrument is evacuated, and the reactor is cooled with liquid nitrogen, and about 10mL of liquid HF is transferred. Reaction 1h. Use an oil pump to pump out HF, remove the reactor, add frozen anhydrous ether to precipitate a solid, and then transfer the suspension to a funnel with a sand core. Wash three times with a small amount of cooled anhydrous ether, and then rinse with 10% acetic acid aqueous solution until the resins no longer adhere to each other, collect the washin...

Embodiment 2

[0160] Example 2: Synthesis of GnRH analogue-paclitaxel conjugates linked by thioether bonds

[0161] Weighing equimolar amounts of the peptide sequence and paclitaxel derivative A in 50% acetonitrile / water solution, reacting with stirring at room temperature, after the reaction was complete, purified by medium-pressure preparative chromatography to obtain a pure product.

[0162] Conjugates were synthesized in this way: 1, 9, 10, 11, 17, 18, 19.

Embodiment 3

[0163] Example 3: Synthesis of Disulfide-Linked GnRH Analogue-Paclitaxel Conjugates

[0164] Weigh the equimolar amount of peptide sequence and paclitaxel derivative B in DMSO, react with stirring at room temperature, after the reaction is complete, purify by medium pressure preparative chromatography to obtain pure product.

[0165] Conjugates were synthesized in this way: 4, 12, 16, 20, 24, 29.

[0166] The mass spectrum characterization data of Example 2 and Example 3 are shown in Table 2.

[0167] Table 2 GnRH analogs - Maldi-Tof-MS Characterization of Paclitaxel Conjugates

[0168]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine and chemistry, and relates to a GnRH analogue-cytotoxic molecule conjugate shown in the formula (1), a preparation method thereof, and application thereof in preparation of medicine for treating tumors. The invention further relates to a stereoisomer or solvate or salt without physiological toxicity of the GnRH analogue-cytotoxic molecule conjugate shown in the formula (1), and a medicine composition comprising the compound. Cytotoxic molecules are coupled with a GnRH analogue through a degradable connecting arm, and the obtained GnRH analogue-taxol conjugate can keep high binding activity with a GnRH receptor, has the good plasma stability and tumor cell growth inhibitory activity, and has the good research significance and prospect.

Description

technical field [0001] The invention belongs to the fields of medicine and chemistry, and in particular relates to a GnRH analogue-cytotoxic molecule conjugate, a preparation method thereof and an application in preparation of drugs for preventing and / or treating tumors. Background technique [0002] Gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH), is a decapeptide hormone secreted by the hypothalamus in pulses (Glp–His–Trp–Ser–Tyr–Gly–Leu–Arg–Pro–Gly ·NH 2 ), is a key molecule regulating the reproductive system. Produced by neurons of the hypothalamus, it reaches the pituitary gland via the portal vein. In the pituitary gland, GnRH activates its receptor GPCR, a seven-fold transmembrane G-protein coupled receptor, thereby promoting the synthesis and secretion of LH (luteinizing hormone) and FSH (follicle stimulating hormone). Recent studies have shown that GnRH also has a role in the hypothalamus and other organs outside ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/23A61K31/337A61K47/48A61P35/00A61P35/02C07K1/107C07K1/06C07K1/04
CPCC07K7/23A61K47/50C07K1/04C07K1/06C07K1/107
Inventor 刘克良周宁马永涛王晨宏冯思良
Owner INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com